XPR – Lifestyle Demo
Author:
Keros Therapeutics, Inc.
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
May 14, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
March 26, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
March 26, 2026